Quantcast

Latest Juvenile Diabetes Research Foundation Stories

2010-03-16 06:55:00

CAMBRIDGE, Mass., March 16 /PRNewswire/ -- Tolerx, Inc., today announced the publication in Diabetologia, the journal of the European Association for the Study of Diabetes, of the four-year follow-up clinical data from new onset type 1 diabetes (T1DM) patients (age 12-39) who received a single short course of therapy with otelixizumab (ChAglyCD3). In this clinical study conducted by the Juvenile Diabetes Research Foundation (JDRF) Center for Beta Cell Therapy in Diabetes based in...

2010-03-15 10:25:00

PHILADELPHIA, March 15 /PRNewswire/ -- When Lee Ducat, founder of the Juvenile Diabetes Research Foundation (JDRF), brought together a group of Philadelphia-area parents of children with juvenile diabetes on May 21, 1970, she could never have imagined that 40 years later that devoted group would have grown into an international organization that changed the world. What started as a mother's vision to help her child has evolved into a foundation with more than 115 chapters in the United...

2010-02-05 14:15:37

Scientists in Cambridge have made a significant step towards developing a so-called "artificial pancreas" system for managing type 1 diabetes in children. The team has developed and successfully tested a new algorithm, providing a stepping stone to home testing for the artificial pancreas. The new study "“ funded by Juvenile Diabetes Research Foundation (JDRF) and published today in The Lancet "“ shows that using an artificial pancreas system overnight can significantly reduce the...

2010-02-05 08:30:00

-- Research Shows Closed-Loop Systems Control Diabetes, Reduce Dangerous Low Blood Sugar -- LONDON, Feb. 5 /PRNewswire-USNewswire/ -- In a landmark study in children and teenagers with type 1 diabetes, JDRF-funded researchers at the University of Cambridge showed that using a first-generation artificial pancreas system overnight can lower the risk of low blood sugar emergencies while sleeping, and at the same time improve diabetes control. Results from the studies are published in the...

2010-02-03 17:01:45

A hormone responsible for the body's stress response is also linked to the growth of insulin-producing cells in the pancreas, according to JDRF- funded researchers at the Salk Institute for Biological Studies in California. The findings are the latest advances to underscore the potential for regeneration as a key component of a possible cure for type 1 diabetes. The research, which was published in the Proceedings of the National Academy of Sciences, was led by Wylie Vale, Ph.D., Professor...

2010-02-02 11:06:00

GERMANTOWN, Md., Feb. 2 /PRNewswire/ -- Sensors for Medicine and Science, Inc., a clinical-stage, medical device company pioneering breakthrough technology that could dramatically improve glucose monitoring for people with diabetes, today announced the appointment of Dr. Paul Strumph as the company's Chief Medical Officer. Dr. Strumph was most recently Vice President and Chief Medical Officer of the Juvenile Diabetes Research Foundation. At JDRF, his responsibilities included overseeing...

2010-01-19 13:00:00

R&D Program Targets Opportunities to Improve Glucose Control and Help People with Diabetes Lead Healthier Lives NEW YORK and FRANKLIN LAKES, N.J., Jan. 19 /PRNewswire-USNewswire/ -- The Juvenile Diabetes Research Foundation (JDRF) and BD (Becton, Dickinson and Company) (NYSE: BDX) announced today an innovative program aimed at improving the treatment of type 1 diabetes by developing novel insulin delivery products to enhance the use of insulin pumps. Through the program, JDRF will...

2010-01-19 08:00:00

Patient Advocacy Partners Forge Collaboration to Fund Discovery of New Drugs that Target the Immune System NEW YORK and MILAN, Italy, Jan. 19 /PRNewswire-USNewswire/ -- Fast Forward, LLC, the commercial drug development arm of the National Multiple Sclerosis Society, and the Juvenile Diabetes Research Foundation (JDRF), the leader in research leading to a cure for type 1 diabetes in the world today announced a collaborative partnership with Axxam SpA -- a leading company in conducting...

2010-01-13 11:00:00

-- Partnership to develop automated system to better control diabetes represents first step on path to artificial pancreas -- NEW YORK, Jan. 13 /PRNewswire-USNewswire/ -- The Juvenile Diabetes Research Foundation today announced an innovative partnership with Animas Corporation to develop an automated system to help people with type 1 diabetes better control their disease -- the first step on the path to what would be among the most revolutionary advancements in treating type 1 diabetes:...

2010-01-11 06:00:00

RICHMOND, Calif., Jan. 11 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced the initiation of two new clinical trials of ZFP Therapeutics, a Phase 2b study in diabetic neuropathy (DN) and a Phase 1 trial in glioblastoma, as well as the renewal of $3.0 million in funding for the Phase 2b trial by the Juvenile Diabetes Research Foundation International (JDRF). Edward Lanphier, Sangamo's president and CEO, will provide an update on the company's ZFP Therapeutic(TM)...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.